End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.49 CNY | +2.90% |
|
-1.40% | -28.87% |
06-25 | Novo Nordisk's Wegovy Weight-Loss Drug Gets Approval in China | DJ |
06-06 | Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic | RE |
ETFs positioned on Huadong Medicine Co., Ltd
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.41% | 1 M€ | -21.61% | - | |
0.99% | 2 M€ | -14.14% | ||
0.12% | 35 M€ | -5.85% | - | |
0.08% | 11 M€ | +5.40% | ||
0.08% | 2 M€ | -0.75% | - | |
0.07% | 4 M€ | -11.56% | ||
0.01% | 114 M€ | +5.17% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 2,838 M€ | +11.07% | - | |
0.01% | 451 M€ | +8.11% | - | |
0.01% | 152 M€ | +6.91% | - | |
0.00% | 35 M€ | +4.88% | - | |
0.00% | 7 M€ | +3.28% | - | |
0.00% | 414 M€ | +11.66% | - | |
0.00% | 36 M€ | +10.51% | - | |
0.00% | 32 M€ | +4.18% | - | |
0.00% | 40 M€ | +6.72% | - | |
0.00% | 324 M€ | +8.24% | - | |
0.00% | 104 M€ | +5.43% | - | |
0.00% | 17 M€ | +3.26% | - |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.87% | 7.1B | |
+29.50% | 77.77B | |
+0.30% | 24.62B | |
+14.70% | 8.75B | |
+0.49% | 8.35B | |
+15.93% | 5.25B | |
+2.27% | 4.1B | |
-8.90% | 3.8B | |
-7.62% | 3.39B | |
+9.36% | 3.25B |
- Stock Market
- Equities
- 000963 Stock
- Funds and ETFs Huadong Medicine Co., Ltd